Evidence map›Paper›PMID 32822476›Full record

ArticleJAMA cardiology2020

Stress Myocardial Perfusion Imaging vs Coronary Computed Tomographic Angiography for Diagnosis of Invasive Vessel-Specific Coronary Physiology: Predictive Modeling Results From the Computed Tomographic Evaluation of Atherosclerotic Determinants of Myocardial Ischemia (CREDENCE) Trial.

Wijnand J Stuijfzand, Alexander R van Rosendael, Fay Y Lin, Hyuk-Jae Chang, Inge J van den Hoogen, Umberto Gianni, Jung Hyun Choi, Joon-Hyung Doh, Ae-Young Her, Bon-Kwon Koo and 31 more

2 registry-linked trialsOpen access · bronzeAbstract readComparative StudyMulticenter Study
In one paragraph

Article in JAMA cardiology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
5.8field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02173275 completednot on this map

Computed TomogRaphic Evaluation of Atherosclerotic DEtermiNants of Myocardial IsChEmia (The CREDENCE Trial)

TypeobservationalSponsorWeill Medical College of Cornell UniversityRan2014 to 2018Enrolled618ConditionsMyocardial Ischemia
NCT06018194 unknown statusnot on this mapstarted 2023, after this paper: background citation

The ELUCIDATE FFRct Study

TypeobservationalSponsorElucid Bioimaging Inc.Ran2023 to 2024Enrolled350ConditionsCoronary Artery DiseaseArmsElucidVivo
3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 77 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. First scan, then treat: 10 years of the SCOT-HEART study.European heart journal supplements : journal of the European Society of Cardiology · 2026
    Article
  5. Article
  6. Article
  7. Coronary artery stenosis, plaque burden, and severity of myocardial ischemia.European heart journal. Imaging methods and practice · 2025
    Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Cardiac computed tomography: from anatomy to function.European heart journal supplements : journal of the European Society of Cardiology · 2023
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

41 authors at 20 institutions in 6 countries.

Wijnand J StuijfzandDalio Institute of Cardiovascular Imaging, Department of Radiology, New York-Presbyterian Hospital and the Weill Cornell Medical College, New York.
Alexander R van RosendaelDalio Institute of Cardiovascular Imaging, Department of Radiology, New York-Presbyterian Hospital and the Weill Cornell Medical College, New York.
Fay Y LinDalio Institute of Cardiovascular Imaging, Department of Radiology, New York-Presbyterian Hospital and the Weill Cornell Medical College, New York.
Hyuk-Jae ChangDivision of Cardiology, Severance Cardiovascular Hospital and Severance Biomedical Science Institute, Yonsei University College of Medicine, Yonsei University Health System, Seoul, South Korea.
Inge J van den HoogenDalio Institute of Cardiovascular Imaging, Department of Radiology, New York-Presbyterian Hospital and the Weill Cornell Medical College, New York.
Umberto GianniDalio Institute of Cardiovascular Imaging, Department of Radiology, New York-Presbyterian Hospital and the Weill Cornell Medical College, New York.
Jung Hyun ChoiPusan National University Hospital, Busan, South Korea.
Joon-Hyung DohDivision of Cardiology, Inje University Ilsan Paik Hospital, Goyang, South Korea.
Ae-Young HerKang Won National University Hospital, Chuncheon, South Korea.
Bon-Kwon KooDepartment of Internal Medicine, Seoul National University Hospital, Seoul, South Korea.
Chang-Wook NamCardiovascular Center, Keimyung University Dongsan Hospital, Daegu, South Korea.
Hyung-Bok ParkDivision of Cardiology, Department of Internal Medicine, International St Mary's Hospital, Catholic Kwandong University College of Medicine, Incheon, South Korea.
Sang-Hoon ShinDivision of Cardiology, Department of Internal Medicine, Ewha Women's University Seoul Hospital, Seoul, South Korea.
Jason ColeMobile Cardiology Associates, Mobile, Alabama.
Alessia GimelliDepartment of Imaging, Fondazione Toscana Gabriele Monasterio, Pisa, Italy.
Muhammad Akram KhanCardiac Center of Texas, McKinney.
Bin LuState Key Laboratory of Cardiovascular Disease, Fuwai Hospital, Beijing, China.
Yang GaoState Key Laboratory of Cardiovascular Disease, Fuwai Hospital, Beijing, China.
Faisal NabiHouston Methodist Hospital, Houston, Texas.
Ryo NakazatoCardiovascular Center, St. Luke's International Hospital, Tokyo, Japan.
U Joseph SchoepfMedical University of South Carolina, Charleston.
Roel S DriessenAmsterdam University Medical Center, VU University Medical Center, Amsterdam, the Netherlands.
Michiel J BomAmsterdam University Medical Center, VU University Medical Center, Amsterdam, the Netherlands.
Randall ThompsonSt Luke's Mid America Heart Institute, Kansas City, Missouri.
James J JangKaiser Permanente Hospital, Oakland, California.
Michael RidnerHeart Center Research, LLC, Huntsville, Alabama.
Chris RowanRenown Heart and Vascular Institute, Reno, Nevada.
Erick AvelarOconee Heart and Vascular Center, St Mary's Hospital, Athens, Georgia.
Philippe GénéreuxGagnon Cardiovascular Institute at Morristown Medical Center, Morristown, New Jersey.
Paul KnaapenAmsterdam University Medical Center, VU University Medical Center, Amsterdam, the Netherlands.
Guus A de WaardAmsterdam University Medical Center, VU University Medical Center, Amsterdam, the Netherlands.
Gianluca PontoneCentro Cardiologico Monzino, IRCCS Milan, Italy.
Daniele AndreiniCentro Cardiologico Monzino, IRCCS Milan, Italy.
Mouaz H Al-MallahHouston Methodist DeBakey Heart and Vascular Center, Houston Methodist Hospital, Houston, Texas.
Yao LuDalio Institute of Cardiovascular Imaging, Department of Radiology, New York-Presbyterian Hospital and the Weill Cornell Medical College, New York.
Daniel S BermanDepartment of Imaging and Medicine, Cedars Sinai Medical Center, Los Angeles, California.
Jagat NarulaMount Sinai Heart, Zena and Michael A. Wiener Cardiovascular Institute, Marie-Josée and Henry R. Kravis Center for Cardiovascular Health, Icahn School of Medicine at Mount Sinai, New York, New York.
James K MinDalio Institute of Cardiovascular Imaging, Department of Radiology, New York-Presbyterian Hospital and the Weill Cornell Medical College, New York.
Jeroen J BaxDepartment of Cardiology, Leiden University Medical Center, Leiden, the Netherlands.
Leslee J ShawDalio Institute of Cardiovascular Imaging, Department of Radiology, New York-Presbyterian Hospital and the Weill Cornell Medical College, New York.
CREDENCE Investigators
New York Hospital Queens · USCentro Cardiologico Monzino · ITNewYork–Presbyterian Hospital · USBaewha Women's University · KRCardiovascular Institute of the South · USCatholic Kwandong University International St. Mary's Hospital · KRCedars-Sinai Medical Center · USCornell University · USFondazione Toscana Gabriele Monasterio · ITFu Wai Hospital · CNHouston Methodist · USInje University Ilsan Paik Hospital · KRKaiser Permanente · USKangwon National University Hospital · KRKeimyung University · KRLeiden University Medical Center · NLMedical University of South Carolina · USMethodist Hospital · USMorristown Medical Center · USPresbyterian Hospital · US

Funding

Patient-Specific Coronary Hemodynamics by 3D PrintingR01HL118019 · NHLBI · WEILL MEDICAL COLL OF CORNELL UNIV · PI DUNHAM, SIMON, LIN, FAY YU-HUEI · 2013 to 2022
$5.8M
NHLBI NIH HHS R01 HL118019
6 · The paper itself

Abstract

Importance: Stress imaging has been the standard for diagnosing functionally significant coronary artery disease. It is unknown whether novel, atherosclerotic plaque measures improve accuracy beyond coronary stenosis for diagnosing invasive fractional flow reserve (FFR) measurement. Objective: To compare the diagnostic accuracy of comprehensive anatomic (obstructive and nonobstructive atherosclerotic plaque) vs functional imaging measures for estimating vessel-specific FFR. Design, Setting, and Participants: Controlled clinical trial of diagnostic accuracy with a multicenter derivation-validation cohort of patients referred for nonemergent invasive coronary angiography. A total of 612 patients (64 [10] years; 30% women) with signs and symptoms suggestive of myocardial ischemia from 23 sites were included. Patients were recruited from 2014 to 2017. Data analysis began in August 2018. Interventions: Patients underwent invasive coronary angiography with measurement of invasive FFR, coronary computed tomographic angiography (CCTA) quantification of atherosclerotic plaque and FFR by CT (FFR-CT), and semiquantitative scoring of rest/stress myocardial perfusion imaging (by magnetic resonance, positron emission tomography, or single photon emission CT). Multivariable generalized linear mixed models were derived and validated calculating the area under the receiver operating characteristics curve. Main Outcomes and Measures: The primary end point was invasive FFR of 0.80 or less. Results: Of the 612 patients, the mean (SD) age was 64 (10) years, and 426 (69.9%) were men. An invasive FFR of 0.80 or less was measured in 26.5% of 1727 vessels. In the derivation cohort, CCTA vessel-specific factors associated with FFR 0.80 or less were stenosis severity, percentage of noncalcified atheroma volume, lumen volume, the number of lesions with high-risk plaque (≥2 of low attenuation plaque, positive remodeling, napkin ring sign, or spotty calcification), and the number of lesions with stenosis greater than 30%. Fractional flow reserve-CT was not additive to this model including stenosis and atherosclerotic plaque. Significant myocardial perfusion imaging predictors were the summed rest and difference scores. In the validation cohort, the areas under the receiver operating characteristic curve were 0.81 for CCTA vs 0.67 for myocardial perfusion imaging (P < .001). Conclusions and Relevance: A comprehensive anatomic interpretation with CCTA, including quantification of obstructive and nonobstructive atherosclerotic plaque, was superior to functional imaging in the diagnosis of invasive FFR. Comprehensive CCTA measures improve prediction of vessel-specific coronary physiology more so than stress-induced alterations in myocardial perfusion. Trial Registration: ClinicalTrials.gov Identifier: NCT02173275.

Indexed as

Coronary AngiographyFractional Flow Reserve, MyocardialMyocardial Perfusion ImagingTomography, X-Ray ComputedAgedFemaleHumansMaleMiddle AgedMyocardial IschemiaPlaque, AtheroscleroticPrognosisProspective Studies

Identifiers

PMID32822476
PMCPMC7439215
OpenAlexW3058098792

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.